GlassScriptPhysician profile
Jonathan Lee Bass
NPI 1487943981
$5,022.91
in general payments reported to CMS, 2019-2025
26 companies · $894 in 2025
The $894 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $39.26 · 2021: $264 · 2022: $2,168 · 2023: $698 · 2024: $469 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,061.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Suvon Surgical LLC | $1,223.94 | 2022-2025 | |
| Trimed, INC. | $608.39 | 2019-2025 | |
| Axogen | $472.96 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Integra Lifesciences Corporation | $446.90 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $278.44 | 2022-2025 | Variax |
| Acumed LLC | $274.43 | 2019-2023 | Acumed |
| Aptis Medical, LLC | $263.85 | 2021 | |
| Polynovo North America LLC | $253.93 | 2023-2025 | Novosorb Btm |
| Allergan, INC. | $148.21 | 2022 | |
| Zimmer Biomet Holdings, INC. | $144.37 | 2024 | A.L.P.S. |
| Mannkind Corporation | $129.51 | 2022 | |
| Mentor Worldwide LLC | $126.97 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Depuy Synthes Sales INC. | $120.71 | 2022 | |
| Endo Pharmaceuticals INC. | $93.11 | 2022-2023 | Xiaflex |
| Arthrosurface Incorporated | $76.99 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $75.15 | 2024-2025 | |
| Abbvie INC. | $53.05 | 2023-2025 | Dalvance |
| Endo USA, INC. | $41.18 | 2024-2025 | Xiaflex |
| Medical Device Business Services, INC. | $40.31 | 2023 | Va-Lcp |
| Merck Sharp & Dohme LLC | $28.09 | 2024 | Keytruda |
| Sumitomo Pharma America, INC. | $24.75 | 2025 | Gemtesa |
| Acell, INC. | $22.97 | 2019 | |
| Urogen Pharma, INC. | $19.64 | 2025 | |
| Solventum Corporation | $19.03 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Medartis INC. | $18.03 | 2023 | Aptus |
| Sonex Health, INC. | $18.00 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.